High-Risk Pregnancy Care: Conditions, Monitoring & Specialist Management

Q: My pregnancy has been labelled "high-risk" — does that mean something will definitely go wrong?

No. The term "high-risk" is a clinical classification that triggers a more intensive monitoring plan — it is not a prediction of a bad outcome. Many women with high-risk pregnancies, including those with gestational diabetes, pre-eclampsia, twins, or prior pregnancy loss, go on to deliver healthy babies. What the classification does is ensure the right surveillance is in place so that problems are caught early, when intervention is most effective. The goal of high-risk pregnancy care is to reduce risk, not to confirm it.

Q: I conceived through IVF — does that automatically make my pregnancy high-risk?

Not automatically, but IVF pregnancies are monitored with an appropriately adjusted plan from the outset. The reasons are factual: IVF is more likely to result in twin pregnancy (even with single embryo transfer, though more so historically); many IVF patients are older, which carries its own risk profile; and the underlying conditions that led to fertility treatment — such as PCOS, uterine factors, or autoimmune conditions — may have implications in pregnancy. At Aansh, the fertility team that managed your IVF cycle hands directly into the obstetric team, so your full history is built into the care plan from the first antenatal booking visit.

Q: What is the difference between gestational hypertension and pre-eclampsia?

Gestational hypertension is newly arising elevated blood pressure (typically ≥ 140/90 mmHg) diagnosed after 20 weeks of gestation, without the additional organ involvement that defines pre-eclampsia. Pre-eclampsia involves hypertension plus signs of organ dysfunction — most commonly protein in the urine (proteinuria), but potentially also abnormal liver function, renal impairment, low platelets, or neurological symptoms. Gestational hypertension requires close monitoring because it can evolve into pre-eclampsia. Both require specialist management; neither should be managed with home observation alone once diagnosed.

Q: Can I continue my regular medications (for diabetes, thyroid, blood pressure) during pregnancy?

Many medications used for these conditions are safe in pregnancy, but some are not, and doses often need adjustment as pregnancy progresses. You should not stop or change any medication without medical advice — but you should review your medications at the booking visit (or, ideally, at a pre-conception counseling appointment before conceiving). Dr. Shweta Agarwal will review all your medications and either confirm they are safe to continue, switch to a pregnancy-safe alternative, or co-ordinate with your treating physician.

Q: What are the warning signs in a high-risk pregnancy that need immediate attention?

Seek same-day review (call +91 80056 85160 immediately) for: severe or sudden headache; visual disturbances (flashing lights, blurred vision, or loss of vision); upper abdominal pain, especially under the right ribs; sudden face, hand, or leg swelling; vaginal bleeding at any stage; reduced or absent fetal movements after 28 weeks; fluid leaking from the vagina before your due date; shortness of breath or chest pain; fever with rigors. Do not wait for the next scheduled appointment for any of these.

Q: I had a preterm birth in my last pregnancy — how does that affect this one?

A previous preterm birth is one of the strongest single predictors of preterm birth in a subsequent pregnancy, and it is factored into the care plan from the first visit. Management may include cervical length monitoring by transvaginal ultrasound, progesterone supplementation, earlier hospital review thresholds, and — if indicated — cervical cerclage. The specific plan depends on the gestation at which your previous preterm birth occurred, the clinical cause, and your cervical length in this pregnancy. This is best discussed at a prenatal counseling appointment before or early in the next pregnancy.

Q: My twins were conceived naturally (not IVF) — do they need to be managed as high-risk?

Yes. Twin pregnancy — regardless of how it was conceived — carries a higher risk of preterm birth, growth discordance, anaemia, gestational diabetes, and pre-eclampsia compared with singleton pregnancy. Monochorionic twins (sharing a placenta) require additional surveillance for twin-to-twin transfusion syndrome. The monitoring plan for twins is adapted accordingly from the outset, with more frequent visits and targeted ultrasound assessments.

Q: What does high-risk pregnancy care cost, and is EMI available?

The cost depends on the specific condition, the frequency of visits and investigations required, and whether specialist co-management is needed. You receive a transparent written cost estimate before any programme begins. Final cost depends on individual clinical evaluation. 0% EMI options are available.

Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO. Last updated: June 2026.

Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.

Aansh Hospital & IVF Center is a growing chain of fertility and women's health centers across Vidarbha and northern Telangana, with its headquarters and in-house embryology lab in Chandrapur, led by Senior Clinical Embryologist Aayush Agarwal, Ph.D. Treatment is led by Dr. Shweta Agarwal (MBBS, DGO). Because fertility treatment, antenatal care, and high-risk obstetric monitoring are all provided under the same roof and by the same clinical team, your history is never lost at handover — from IVF to booking visit to high-risk pathway, the care is continuous. You can verify our government ART registration on the National ART & Surrogacy Registry.

What makes a pregnancy "high-risk"?

A pregnancy is classified as high-risk when one or more factors — present before conception, arising in the first trimester at booking, or developing during the pregnancy — meaningfully increase the risk of complications for the mother or baby. These factors fall into three broad groups.

Pre-existing maternal conditions:

Diabetes mellitus (Type 1 or Type 2) — elevated blood glucose affects fetal growth, organ development, and delivery planning; requires tight glycaemic control throughout.
Hypertension (chronic) — pre-existing high blood pressure increases the risk of superimposed pre-eclampsia, growth restriction, and preterm birth.
Thyroid disorders — both hypothyroidism and hyperthyroidism are common in Indian women; poorly controlled thyroid function is associated with miscarriage, growth restriction, and fetal neurodevelopment concerns.
Cardiac conditions — structural or functional heart disease requires cardiology co-management and careful assessment of haemodynamic demand as pregnancy progresses.
Autoimmune conditions (e.g. systemic lupus erythematosus, antiphospholipid syndrome) — may affect placentation, increase clotting risk, and require specialist co-management.
Renal disease, clotting disorders, severe anaemia.

Obstetric history:

Prior pregnancy loss (one or more miscarriages or second-trimester losses).
Previous preterm birth — one of the strongest predictors of preterm birth in a subsequent pregnancy.
Previous caesarean section — especially relevant to planning mode of delivery and for placenta positioning.
Cervical insufficiency (also called cervical incompetence) — a shortened or functionally weak cervix that may require cervical cerclage or progesterone support.
Previous stillbirth.
Previous baby with a chromosomal or structural condition.

Complications arising in the current pregnancy:

Pre-eclampsia or gestational hypertension (see detailed section below).
Gestational diabetes mellitus (GDM).
Placenta praevia (low-lying placenta that may cover the cervix).
Intrauterine growth restriction (IUGR) / fetal growth restriction (FGR) — the fetus is measuring smaller than expected for gestation.
Multiple pregnancy — twins or higher-order multiples.

Maternal age: Both very young mothers (adolescent pregnancy) and mothers above 35 — particularly above 40 — face a different risk profile than the average maternal age range. Older maternal age is associated with a higher background rate of chromosomal variation, gestational hypertension, gestational diabetes, and operative delivery. These are factual, age-related biological considerations; they do not mean a good outcome is not achievable, and they are managed proactively rather than simply noted.

What are the specific conditions that are managed under this pathway?

Pre-eclampsia and gestational hypertension

Pre-eclampsia is a pregnancy-specific condition characterised by newly arising hypertension (typically ≥ 140/90 mmHg, per FOGSI/ICMR guidelines) combined with organ involvement — classically proteinuria (protein in the urine), but also potentially liver, kidney, haematological, or neurological features. It most commonly presents after 20 weeks of gestation. Gestational hypertension is elevated blood pressure in pregnancy without the additional organ features; it may evolve into pre-eclampsia and requires close monitoring.

Management includes blood pressure monitoring at every visit, urine protein checks, blood investigations (LFT, renal function, platelet count) at appropriate intervals, fetal growth and wellbeing assessment via ultrasound, and antihypertensive medication when indicated. Timing and mode of delivery is planned based on the severity and gestational age at presentation.

Warning signs that require same-day review: severe headache, visual disturbances (flashing lights or blurred vision), sudden upper abdominal pain (especially right-sided under the ribs), rapidly increasing facial or hand swelling. Call +91 80056 85160 immediately if these arise.

Gestational diabetes mellitus (GDM)

GDM is glucose intolerance first identified in pregnancy. It is particularly prevalent in Indian women — Indian ethnicity carries a higher background risk of insulin resistance — with a national prevalence of approximately 22.4% (per the ICMR-INDIAB 2025 study). GDM is identified through screening, typically an oral glucose tolerance test (OGTT) at around 24–28 weeks, with earlier testing for high-risk women (previous GDM, family history of diabetes, PCOS, obesity). In India, GDM is diagnosed using a single-step 75g oral glucose tolerance test (OGTT) in a non-fasting state, where a 2-hour plasma glucose value of ≥ 140 mg/dL is diagnostic (per DIPSI and Ministry of Health & Family Welfare guidelines).

When identified, GDM is managed through dietary modification (carbohydrate distribution, glycaemic index guidance), regular blood glucose monitoring, and — where diet is insufficient — medication or insulin. Well-managed GDM is associated with outcomes that are substantially better than undetected or poorly managed GDM. Maternal glucose control affects fetal size (risk of macrosomia — an excessively large baby — as well as, paradoxically, growth restriction in some subtypes), delivery planning, and newborn care.

Intrauterine growth restriction (IUGR) / fetal growth restriction (FGR)

IUGR describes a fetus that is not reaching its growth potential — identified when fetal measurements on ultrasound fall below expected norms for gestational age, particularly when accompanied by abnormal Doppler blood-flow patterns in the umbilical artery or fetal vessels. It is distinct from a constitutionally small baby (small for gestational age with normal Doppler and normal liquor). True IUGR carries risk of fetal distress, preterm birth, and neonatal complications, and requires intensified monitoring.

Management involves serial growth assessments, Doppler blood-flow studies (for fetal wellbeing — not sex determination), amniotic fluid assessment, and careful planning of the timing and mode of delivery to balance fetal maturity against the risk of continuing the pregnancy. Detailed fetal surveillance in this context is described on our fetal monitoring page.

Placenta praevia

Placenta praevia is the condition in which the placenta is situated in the lower part of the uterus, partially or completely covering the internal cervical os. It is associated with painless antepartum haemorrhage (vaginal bleeding) in the second and third trimester. The position of the placenta is assessed at the anomaly scan (typically 18–22 weeks); many low-lying placentas identified early resolve as the lower uterine segment develops. Those that persist require a modified management plan including restriction of activity, close monitoring for bleeding, and planned caesarean delivery, with follow-up scans typically scheduled at 32 weeks and, if still low-lying, at 36 weeks (per RCOG/FOGSI guidelines).

Multiple pregnancy (twins and higher-order multiples)

Twin pregnancy occurs more frequently after IVF and ART than after spontaneous conception — because of the practice of transferring embryos (and, historically, transferring more than one). Even with single embryo transfer (SET), which Aansh recommends as standard practice, naturally conceived twins do occur. Twin pregnancies carry a higher risk of: preterm birth, growth discordance between the twins, pre-eclampsia, gestational diabetes, anaemia, and (in monochorionic — identical — twins) twin-to-twin transfusion syndrome. Chorionicity (whether twins share a placenta) is determined at the first-trimester scan and determines the monitoring schedule.

The increased monitoring in IVF pregnancies is not cause for alarm — it reflects a sensible, evidence-based upward adjustment based on the known statistics. See realistic expectations after IVF for a broader discussion of IVF pregnancy outcomes.

Cervical insufficiency

Cervical insufficiency (previously called cervical incompetence) describes a cervix that shortens or dilates before the pregnancy is at term, leading to second-trimester pregnancy loss or very preterm delivery. It is often identified by a history of painless mid-trimester loss or, on surveillance, by a short cervical length on transvaginal ultrasound. Management options include cervical cerclage (a stitch placed in the cervix under anaesthesia) and/or progesterone supplementation, along with modified activity guidance and close monitoring. Guidelines recommend progesterone or cerclage when the cervical length is short (typically <25 mm) before 24 weeks of gestation in women with a history of preterm birth (per RCOG/ACOG/FOGSI guidelines).

Why are IVF and ART pregnancies monitored more closely?

An IVF pregnancy is biologically similar to a spontaneous pregnancy in most respects, but a few factual considerations mean the monitoring plan is appropriately adjusted from the start — not because something is wrong, but because the evidence supports closer surveillance.

Multiple pregnancy is more common after IVF (even with standard SET, and more so historically when two embryos were transferred). Twins and higher-order multiples carry genuinely higher obstetric risk, and the monitoring plan reflects this.
Maternal age: many IVF patients are in their mid-thirties or older — not because IVF causes age-related risk, but because age is often part of why fertility treatment was needed. The age-related risk profile applies regardless of how conception occurred.
Underlying subfertility cause: conditions such as PCOS, endometriosis, uterine anomalies, or autoimmune factors that contributed to subfertility may also have implications in pregnancy. These are already known from the fertility assessment and are factored into the care plan from the outset.
The team already knows your history. At Aansh, continuity from fertility assessment through IVF into antenatal care and then into high-risk monitoring means no clinical information is lost and no investigation is duplicated unnecessarily.

How is a high-risk pregnancy managed at each stage?

High-risk pregnancy management is not a single intervention — it is a structured, dynamic care plan that adapts as the pregnancy progresses. Key components include:

More frequent clinical visits: Where a standard antenatal programme involves visits spaced several weeks apart, a high-risk pregnancy typically involves more frequent review — sometimes fortnightly or weekly, depending on the condition and gestation. This allows earlier detection of deterioration and timely intervention.

Targeted fetal surveillance: Serial growth scans assess fetal size and growth velocity across multiple timepoints (not a single measurement). Doppler studies assess blood flow in the umbilical artery and fetal vessels as a marker of fetal wellbeing and placental function — these are anatomy and wellbeing assessments conducted strictly in accordance with the PCPNDT Act. Cardiotocography (CTG) is used in the third trimester to assess fetal heart rate patterns. Detailed fetal surveillance protocols are described on our fetal monitoring page.

Control of underlying conditions: Tight glycaemic control in diabetic pregnancies. Blood pressure management with medications safe in pregnancy. Thyroid function optimisation (TSH monitoring and dose adjustment). Anticoagulation where indicated for clotting disorders or antiphospholipid syndrome. These are managed in co-ordination with the relevant medical specialist (physician, endocrinologist, cardiologist) where needed.

Specialist obstetric input and co-management: Some high-risk pregnancies benefit from or require co-management with a maternal-fetal medicine (MFM) specialist, cardiologist, nephrologist, or endocrinologist. Where referral to a higher-level facility — including a neonatal intensive care unit (NICU) for anticipated preterm delivery or a sick neonate — is clinically anticipated, this is planned in advance rather than arranged as an emergency.

Delivery planning: Mode of delivery (vaginal versus caesarean), place of delivery, and timing of delivery are all part of the high-risk management plan. Decisions are made based on the specific condition, its severity at the time, fetal wellbeing, and gestational age — not on a single rule applied universally. For placenta praevia, caesarean delivery is standard. For pre-eclampsia, the timing depends on severity and gestation. For IUGR, the decision balances fetal maturity against fetal wellbeing signals.

What can patients do to support their own care?

Active engagement in your care directly affects outcomes. Practical, evidence-based steps:

Attend every scheduled visit — the monitoring programme only works if all data points are collected.
Monitor blood pressure at home if prescribed a home monitor — record readings and bring the log to every visit.
Blood glucose monitoring (for GDM): follow your glucose diary, record every reading, and flag patterns to the team.
Fetal movement awareness (from approximately 28 weeks): become familiar with your baby's usual movement pattern. A reduction in your baby's normal movement pattern is a reason to seek same-day review — call +91 80056 85160 or WhatsApp +91 80056 85160.
Medication adherence: take prescribed antihypertensives, insulin, iron, progesterone, or anticoagulants as directed — stopping without advice can destabilise the condition quickly.
Report symptoms promptly: do not wait for the next scheduled appointment if you develop warning symptoms (see pre-eclampsia section above, and the antenatal care warning signs page).
Pre-conception planning for future pregnancies: if you have had a high-risk pregnancy before, a prenatal counseling consultation before your next pregnancy allows the risk profile to be assessed and optimised ahead of time.

When is referral or co-management with a higher-level facility needed?

Most high-risk pregnancies can be well managed with intensified surveillance, condition-specific treatment, and planned delivery — without requiring transfer to a tertiary centre. However, certain situations benefit from or require access to higher-level facilities:

Anticipated very preterm delivery (typically before 32 weeks, per National Neonatology Forum guidelines) where a neonatal intensive care unit (NICU) is needed for the newborn.
Cardiac disease requiring intrapartum anaesthetic or intensive care support.
Conditions requiring maternal intensive care (severe pre-eclampsia with multi-organ involvement, haemorrhage risk in placenta praevia).
Fetal conditions requiring neonatal surgical intervention.

Where referral or co-management is needed, this is planned in advance — not as an emergency — and the team facilitates the transition with full clinical documentation. Patients are never simply handed over; where possible, the Aansh team continues to co-manage alongside the receiving facility.

Good to know

Frequently asked questions

My pregnancy has been labelled "high-risk" — does that mean something will definitely go wrong?

No. The term "high-risk" is a clinical classification that triggers a more intensive monitoring plan — it is not a prediction of a bad outcome. Many women with high-risk pregnancies, including those with gestational diabetes, pre-eclampsia, twins, or prior pregnancy loss, go on to deliver healthy babies. What the classification does is ensure the right surveillance is in place so that problems are caught early, when intervention is most effective. The goal of high-risk pregnancy care is to reduce risk, not to confirm it.

I conceived through IVF — does that automatically make my pregnancy high-risk?

Not automatically, but IVF pregnancies are monitored with an appropriately adjusted plan from the outset. The reasons are factual: IVF is more likely to result in twin pregnancy (even with single embryo transfer, though more so historically); many IVF patients are older, which carries its own risk profile; and the underlying conditions that led to fertility treatment — such as PCOS, uterine factors, or autoimmune conditions — may have implications in pregnancy. At Aansh, the fertility team that managed your IVF cycle hands directly into the obstetric team, so your full history is built into the care plan from the first antenatal booking visit.

What is the difference between gestational hypertension and pre-eclampsia?

Gestational hypertension is newly arising elevated blood pressure (typically ≥ 140/90 mmHg, per FOGSI/ICMR guidelines) diagnosed after 20 weeks of gestation, without the additional organ involvement that defines pre-eclampsia. Pre-eclampsia involves hypertension plus signs of organ dysfunction — most commonly protein in the urine (proteinuria), but potentially also abnormal liver function, renal impairment, low platelets, or neurological symptoms. Gestational hypertension requires close monitoring because it can evolve into pre-eclampsia. Both require specialist management; neither should be managed with home observation alone once diagnosed.

Can I continue my regular medications (for diabetes, thyroid, blood pressure) during pregnancy?

Many medications used for these conditions are safe in pregnancy, but some are not, and doses often need adjustment as pregnancy progresses. You should not stop or change any medication without medical advice — but you should review your medications at the booking visit (or, ideally, at a pre-conception counseling appointment before conceiving). Dr. Shweta Agarwal will review all your medications and either confirm they are safe to continue, switch to a pregnancy-safe alternative, or co-ordinate with your treating physician.

What are the warning signs in a high-risk pregnancy that need immediate attention?

Seek same-day review (call +91 80056 85160 immediately) for: severe or sudden headache; visual disturbances (flashing lights, blurred vision, or loss of vision); upper abdominal pain, especially under the right ribs; sudden face, hand, or leg swelling; vaginal bleeding at any stage; reduced or absent fetal movements after 28 weeks; fluid leaking from the vagina before your due date; shortness of breath or chest pain; fever with rigors. Do not wait for the next scheduled appointment for any of these.

I had a preterm birth in my last pregnancy — how does that affect this one?

A previous preterm birth is one of the strongest single predictors of preterm birth in a subsequent pregnancy, and it is factored into the care plan from the first visit. Management may include cervical length monitoring by transvaginal ultrasound, progesterone supplementation, earlier hospital review thresholds, and — if indicated — cervical cerclage. The specific plan depends on the gestation at which your previous preterm birth occurred, the clinical cause, and your cervical length in this pregnancy. This is best discussed at a prenatal counseling appointment before or early in the next pregnancy.

My twins were conceived naturally (not IVF) — do they need to be managed as high-risk?

Yes. Twin pregnancy — regardless of how it was conceived — carries a higher risk of preterm birth, growth discordance, anaemia, gestational diabetes, and pre-eclampsia compared with singleton pregnancy. Monochorionic twins (sharing a placenta) require additional surveillance for twin-to-twin transfusion syndrome. The monitoring plan for twins is adapted accordingly from the outset, with more frequent visits and targeted ultrasound assessments.

What does high-risk pregnancy care cost, and is EMI available?

The cost depends on the specific condition, the frequency of visits and investigations required, and whether specialist co-management is needed. You receive a transparent written cost estimate before any programme begins. Final cost depends on individual clinical evaluation. See fees and EMI options for a current overview. 0% EMI options are available.

We listen first

Take the first step — privately, at your own pace

Message us on WhatsApp or call. No medical history is needed to start the conversation, and nothing is decided in one visit.

Message on WhatsApp Call +91 80056 85160